Structural basis for inhibition of human PNP by immucillin-H

Biochem Biophys Res Commun. 2003 Oct 3;309(4):917-22. doi: 10.1016/j.bbrc.2003.08.094.

Abstract

Purine nucleoside phosphorylase (PNP) catalyzes the phosphorolysis of the N-ribosidic bonds of purine nucleosides and deoxynucleosides. PNP is a target for inhibitor development aiming at T-cell immune response modulation. This work reports on the crystallographic study of the complex of human PNP-immucillin-H (HsPNP-ImmH) solved at 2.6A resolution using synchrotron radiation. Immucillin-H (ImmH) inhibits the growth of malignant T-cell lines in the presence of deoxyguanosine without affecting non-T-cell tumor lines. ImmH inhibits activated normal human T cells after antigenic stimulation in vitro. These biological effects of ImmH suggest that this agent may have utility in the treatment of certain human diseases characterized by abnormal T-cell growth or activation. This is the first structural report of human PNP complexed with immucillin-H. The comparison of the complex HsPNP-ImmH with recent crystallographic structures of human PNP explains the high specificity of immucillin-H for human PNP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Crystallography, X-Ray
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Ligands
  • Models, Molecular
  • Protein Conformation
  • Purine Nucleosides
  • Purine-Nucleoside Phosphorylase / antagonists & inhibitors*
  • Purine-Nucleoside Phosphorylase / chemistry
  • Pyrimidinones / pharmacology*
  • Pyrroles / pharmacology*

Substances

  • Enzyme Inhibitors
  • Ligands
  • Purine Nucleosides
  • Pyrimidinones
  • Pyrroles
  • forodesine
  • Purine-Nucleoside Phosphorylase